Healthcare - Biotechnology - NASDAQ - US
$ 0.814
-2.78 %
$ 102 M
Market Cap
-0.78
P/E
Price Target
Average
710.81%
Revenue Forecast
Estimate
19.50%
EBIT
Estimate
--17.68%
Net Income
Estimate
48.96%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Karyopharm Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for KPTI of $6.6 , with forecasts ranging from a low of $3 to a high of $14 .
KPTI Lowest Price Target
Wall Street Target
3 USD
268.55%
KPTI Average Price Target
Wall Street Target
6.6 USD
710.81%
KPTI Highest Price Target
Wall Street Target
14 USD
1619.90%
REVENUE FORECAST
Revenue Forecast Chart KPTI
EBIT FORECAST
EBIT Forecast Chart KPTI
NET INCOME FORECAST
Net Income Chart KPTI